This World Tuberculosis Day, we're awarding over £130,000 in funding to five new collaborative tuberculosis (TB) projects, led by mid-career researchers in Africa and the UK.
Through their research, Dr Esto Bahizire and Dr Naomi Walker aim to better understand tuberculosis in eastern Democratic Republic of the Congo, where there is a high burden of the infection.
Tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuberculosis (Mtb), is a global health emergency.
Most TB is curable if appropriately diagnosed and treated. However, multidrug-resistant TB (MDR-TB) is resistant to rifampicin and isoniazid, two key antibiotics in TB treatment regimens, and is therefore much harder to treat.
Diagnosing MDR-TB is a challenge for resource-limited settings, including in eastern Democratic Republic of the Congo (DRC), where there is an extremely high burden of TB, but vital information on drug resistance is lacking.
This research is a collaboration between investigators at Catholic University of Bukavu and Liverpool School of Tropical Medicine as well as UK Health Security Agency.
Dr Esto Bahizire and Dr Naomi Walker will investigate MDR-TB in Eastern DRC by studying mycobacterial culture and whole genome sequencing (WGS) of isolates from patients with pulmonary TB in South Kivu province. Their aim is to unravel the genetics of MDR-TB and associate these with patient outcomes.
This project has been funded by the 2022 Dorothy Temple Cross International Collaboration Grant.
Get in touch
To find out more about the research we fund and the difference it makes.Contact us
Help change lives
We fund and support the most promising health research wherever we discover great opportunities that are not being pursued. We use our donations responsibly and ensure we make the greatest impact where it is most needed.Donate